Cargando...
MiR-29b reverses oxaliplatin-resistance in colorectal cancer by targeting SIRT1
Oxaliplatin is a commonly used chemotherapeutic drug for the treatment of advanced colorectal cancer. However, acquired drug resistance against oxaliplatin remains a major obstacle for efficient use of it, and mechanisms underlying oxaliplatin resistance are still required to be explored. In the pre...
Guardado en:
| Publicado en: | Oncotarget |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Impact Journals LLC
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5844747/ https://ncbi.nlm.nih.gov/pubmed/29552311 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.24380 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|